
Basic principles of physiologically-based pharmacokinetic (PBPK) modeling and its impact in streamlining the drug development process are reviewed.
Stephen D. Hall is senior research fellow, drug disposition, Eli Lilly and Co.
Basic principles of physiologically-based pharmacokinetic (PBPK) modeling and its impact in streamlining the drug development process are reviewed.
Published: March 16th 2021 | Updated: